Setting Up a Clinical Distribution Record Map

A clinical distribution record map should be established before the first investigational device is shipped. It defines how each physical movement or status change will be documented, which record is authoritative, and who is responsible for resolving differences.

Without that structure, a study may generate extensive documentation while still being unable to show a complete and consistent chain of accountability.

Map the Complete Distribution Pathway

The map should follow the device through the intended distribution pathway: release by the manufacturer, import, receipt at the central facility, storage, shipment authorization, picking and packing, carrier handover, site delivery, site receipt, patient or subject use, return, quarantine, rebalancing, destruction, or other final disposition.

For each event, the sponsor should identify the source document, the system in which the event is recorded, the required data fields, and the expected completion time.

Distinguish the System of Record From Supporting Evidence

Several systems may contribute to the distribution record. These can include the sponsor’s clinical trial management or electronic trial master file system, the distributor’s inventory system, carrier tracking platforms, temperature-monitoring systems, site accountability logs, case report forms, and exception or complaint records.

The record map should distinguish the system of record from supporting evidence. A carrier proof of delivery, for example, may confirm arrival but does not necessarily establish that the site inspected, accepted and entered the devices into accountable inventory.

Standardize Identifiers Across Systems

Study number, site number, product or kit code, lot or serial number, expiration date, shipment number, return authorization, inventory status and disposition reference should mean the same thing across systems.

Where a patient or subject identifier is needed, its use should be limited to the minimum necessary and kept out of logistics records that do not require it.

Assign Reconciliation Responsibilities

Responsibility for reconciliation should be explicit. The map should state who enters each record, who reviews it, who investigates discrepancies, who authorizes corrections, and where final evidence is retained.

It should also define how transfers, damaged units, temperature excursions, missing confirmations and late site entries affect inventory status.

Control Changes to the Record Map

Changes to the record map should be controlled when the protocol, product configuration, site model or distribution pathway changes.

Updating the map as the study evolves helps preserve consistent definitions, responsibilities and reconciliation rules across all participating systems and organizations.

Establish the Framework During Study Setup

MDD Studies can build the clinical distribution record map as part of study setup, align sponsor, manufacturer, carrier, warehouse and site records, configure study-specific identifiers and inventory statuses, and establish reconciliation and escalation responsibilities before release of the first shipment.

This creates an operational framework in which investigational devices and the records supporting them can be managed together throughout the study.